Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 17, 2009

PerkinElmer Assay Platform to Be Leveraged in Korea’s Sangmyung University’s GPCR Research

  • Sangmyung University of the Republic of Korea inked an agreement to use PerkinElmer’s assays in GPCR research. The deal is part of the country’s efforts to establish an academic GPCR screening facility together with the Korea Chemical Bank, a national repository library of over 100,000 small molecule compounds.

    PerkinElmer reports that its AequoScreen aequorin assays is based on sensitive and flexible cell-based technology with advantages over conventional fluorescence-based dyes, including fewer false positives, simpler protocol, and increased assay windows.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »